Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 25;11:1758835919864850. doi: 10.1177/1758835919864850

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2019

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 6. — Correlation of MCL-1 protein expression in pretreatment tumor cells with overall survival and recurrence free survival of patients with locoregional esophageal adenocarcinoma treated with neoadjuvant chemoradiation and surgery.

(A) Photomicrograph of MCL-1 immunohistochemical staining of a pretreatment tumor with low MCL-1 expression (200× magnification). (B) Photomicrograph of MCL-1 immunohistochemical staining of a pretreatment tumor with high MCL-1 expression (200× magnification). (C) Kaplan–Meier overall survival curves for patients with high tumor MCL-1 expression and patients with low tumor MCL-1 expression. (D) Kaplan–Meier recurrence free (or time to death) survival curves for patients with high tumor MCL-1 expression and patients with low tumor MCL-1 expression.